Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
That same month I asked the Biden administration to reconsider its decision to reject a petition from cancer patients to substantially lower the price of the prostate cancer drug Xtandi by allowing companies to manufacture generic versions of it at a much lower price.
- Simplified Text
-
Sanders asked Biden administration to reconsider rejecting petition to lower Xtandi price.
- Confidence Score
- 0.500
- Claim Maker
- Bernie Sanders
- Context Type
- Website Article
- Context Details
-
{ "date": null } - Subject Tags
- UUID
- 9fdb2e84-cc37-44f9-8337-62d6068ed279
- Vector Index
- ✗ No vector
- Created
- September 12, 2025 at 12:34 AM (9 hours ago)
- Last Updated
- September 12, 2025 at 12:34 AM (9 hours ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
44
claims
🔥
9 hours ago
https://www.sanders.senate.gov/op-eds/the-greed-of-big-pharma-cannot-continue/
Senator Sanders criticizes exorbitant prescription drug prices in the US, highlighting the industry's lobbying power and advocating for price controls.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.